Globus Medical Reports Fourth Quarter and Full Year 2023 Results
AUDUBON, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced […]
SiriusPoint reports 89.1% Combined ratio for its Core operations with Net Income up $742m from FY 22
HAMILTON, Bermuda, Feb. 20, 2024 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE:SPNT) today announced results for its […]
Alpine Income Property Trust Declares Dividend For the First Quarter 2024
WINTER PARK, Fla., Feb. 20, 2024 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today […]
CTO Realty Growth Declares Dividends For the First Quarter 2024
WINTER PARK, Fla., Feb. 20, 2024 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) announced […]
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024
REDWOOD CITY, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel […]
Arteris Announces Financial Results for the Fourth Quarter and Full Year 2023 and Estimated First Quarter and Full Year 2024 Guidance
CAMPBELL, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates […]
LegalZoom to Participate in Upcoming Investor Conferences
MOUNTAIN VIEW, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — LegalZoom.com, Inc. (Nasdaq: LZ), the No. 1 choice in online small […]
Stitch Fix Announces Date for Second Quarter 2024 Financial Results and Conference Call
SAN FRANCISCO, Feb. 20, 2024 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, today […]
Arvinas Announces Chief Financial Officer Transition
– Sean Cassidy leaving Arvinas as of February 29, 2024 – – Randy Teel, Ph.D. to assume the role of […]
CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWARK, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing […]
